Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grzegorz S Nowakowski

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Highlights in large B-cell lymphoma and follicular lymphoma from the 66th ASH Annual Meeting and Exposition: commentaryGrzegorz S Nowakowski
Blood|August 8, 2015
Evolution: IMiDs to PPMs, revolution in DLBCL?Grzegorz S Nowakowski
Clinical Advances in Hematology & Oncology : H&O|May 14, 2021
Recently approved drugs herald a new era in therapy for diffuse large B-cell lymphomaGrzegorz S Nowakowski
Blood|June 25, 2008
Gang of 3 in aggressive CLL?Grzegorz S Nowakowski
PET Clinics|May 16, 2019
End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell LymphomaLale Kostakoglu, Grzegorz S Nowakowski
Current Hematologic Malignancy Reports|May 7, 2020
Treatment of Aggressive B Cell Lymphomas: Updates in 2019Patrizia Mondello, Grzegorz S Nowakowski
Neurology|December 11, 2002
Epilepsia partialis continua as an atypical presentation of cat scratch disease in a young adultGrzegorz S Nowakowski, Amiram Katz
Future Oncology (London, England)|February 11, 2017
Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphomaGrzegorz S Nowakowski, Umberto Vitolo
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Radioimmunotherapy for B-cell non-Hodgkin lymphomaGrzegorz S Nowakowski, Thomas E Witzig
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?Grzegorz S Nowakowski, Myron S Czuczman
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Highlights in large B-cell lymphoma and follicular lymphoma from the 66th ASH Annual Meeting and Exposition: commentaryGrzegorz S Nowakowski
Blood|August 8, 2015
Evolution: IMiDs to PPMs, revolution in DLBCL?Grzegorz S Nowakowski
Clinical Advances in Hematology & Oncology : H&O|May 14, 2021
Recently approved drugs herald a new era in therapy for diffuse large B-cell lymphomaGrzegorz S Nowakowski
Blood|June 25, 2008
Gang of 3 in aggressive CLL?Grzegorz S Nowakowski
PET Clinics|May 16, 2019
End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell LymphomaLale Kostakoglu, Grzegorz S Nowakowski
Current Hematologic Malignancy Reports|May 7, 2020
Treatment of Aggressive B Cell Lymphomas: Updates in 2019Patrizia Mondello, Grzegorz S Nowakowski
Neurology|December 11, 2002
Epilepsia partialis continua as an atypical presentation of cat scratch disease in a young adultGrzegorz S Nowakowski, Amiram Katz
Future Oncology (London, England)|February 11, 2017
Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphomaGrzegorz S Nowakowski, Umberto Vitolo
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Radioimmunotherapy for B-cell non-Hodgkin lymphomaGrzegorz S Nowakowski, Thomas E Witzig
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?Grzegorz S Nowakowski, Myron S Czuczman
Pageof 22